インフォショップ ホームへ 株式会社グローバルインフォメーション
サイトマップ
その他のカテゴリ

商品カタログ

医療/バイオの調査資料販 MEDINFO.JP

先端癌治療特集
BioSeeker Group - 先端癌治療特集ページ 用途別にデータベース、調査資料等をご紹介いたします
BioSeeker Group社
発行

Drug Development China 公式サイト

World Vaccine Congress Australia 2008 公式サイト

Drug Discovery & Development of Innovative Therapeutics India 公式サイト

Discovery2Diagnostics 公式サイト

Discovery On Target 公式サイト

2nd Annual Healthcare Operations Management 公式サイト

Drug Delivery Technology Asia 2008 公式サイト

Post-Approval Drug Safety Strategies 公式サイト
English Korean
【 英文市場調査報告書 】

糖尿病におけるグルコースモニタリング機器の世界市場:将来市場は発展途上国

Strategic Analysis of World Diabetes Glucose Monitoring Devices Markets

商品コード : 22368 Frost & Sullivan
出版日: 2004/02
発行 : Frost & Sullivan
電話でのお問い合わせ
価格情報
概要 原文目次
※この商品は英文にてご提供いたします。

Abstract

Developing Countries Emerging as Key Markets for Diabetes Monitoring Devices

The demand for glucose self-monitoring devices has seen tremendous growth in recent years. Developing countries are rapidly emerging as important markets for these devices, spurred by growing awareness, availability of sophisticated self-monitoring technologies, and greater purchasing power. This is evident from the strong growth experienced by participants in these countries during the 2002-2003 time period even as they were undergoing a relatively slow growth phase in the U.S. market.

This strategic analysis service (SAS) from Frost & Sullivan is a visual presentation of the latest trends in the global diabetes glucose monitoring devices markets and their three segments: glucose meters, glucose test strips, and continuous glucose monitoring systems. It examines the significant challenges faced by participants and recommends strategies to overcome the same. Market metrics include segment-wise revenue forecasts, pricing trends, identification of emerging opportunities, and detailed information on competitive positioning of leading companies.

A ?eFree Meter?f Market Relies Heavily on Test Strips for Higher Profitability

The glucose self-monitoring devices business has often been described as a ?efree meter market?f because of the heavy discounts offered on glucose meters. In most cases, glucose meters, priced between $45 and $100 are distributed free with the purchase of multiple packs of glucose test strips. Due to this, equipment manufacturers consider meters as ?eloss leaders?f and try to amortize their cost over a specific time period. The challenge for manufacturers lies in patient selection and distribution of free meters to these ?eideal?f patients that are likely to use test strips and meters frequently and generate repeat sales.

Consumer-driven Marketing Campaigns – Essential, though Expensive

Key market participants have traditionally focused their selling efforts on professional healthcare agencies such as the Managed Care and Medicaid or Medicare that exercised considerable influence on purchase decisions. This is gradually changing with leading companies such as Roche, LifeScan, Bayer, and Abbott Laboratories beginning to focus on direct-to-consumer advertising. They are channeling significant funds toward such campaigns to differentiate their products, generate recall, and create brand recognition.

"Brand awareness is extremely important as most consumers ?eself-select?f their glucose monitoring kit," says the analyst. "Though healthcare professionals are highly influential in the initial purchase decision, subsequent upgrades and/or purchases are often based on multiple factors, with advertising through media being a key strategy."

Escalating Expenditure for R&D and Marketing Triggers Consolidation

"Marketing and R&D expenditures have skyrocketed following the consumer-focused approach adopted by device manufacturers," says the analyst. This has triggered industry-wide consolidation across the world. One recent example for such consolidation is the acquisition of TheraSense, Inc. by Abbott Laboratories. Many small and niche companies lack sufficient funding and hence, look for collaboration with resource-rich large companies to strengthen their growth prospects. Collaborations are likely to benefit even large companies as they seek opportunities in developing countries to extend their market reach.

Table of Contents

  • SAS REPORT
    • Introduction
      • Introduction
      • Overview
    • Market Dynamics
      • Market Dynamics
      • Challenges
      • Drivers and Restraints
      • Market Trends
    • Market Forecasts
      • Market Forecasts
      • Global Forecasts
      • Global Revenue Growth Rates
      • Revenue Forecasts by Segment
      • Global Market Share
    • Emerging Technology
      • Emerging Technology Market Trends
      • Product Profiles
      • R&D and Technology Trends
    • Competitive Landscape
      • Competitive Landscape
      • Competitive Profiles
      • CEO / VP Outlook
      • Product Lifecycle Analysis
    • Econometrics
      • Macroeconomic Analysis
    • Future Outlook
      • Future Outlook
    • Frost & Sullivan Awards
      • Frost & Sullivan Awards
    • About Our Company
      • Our Team
      • Consulting Capabilities
概要 原文目次
※この商品は英文にてご提供いたします。
【 英文市場調査報告書 】
糖尿病におけるグルコースモニタリング機器の世界市場:将来市場は発展途上国
Strategic Analysis of World Diabetes Glucose Monitoring Devices Markets
出版日: 2004/02
電話でのお問い合わせ
この商品について問い合わせる
この商品のサンプル(抜粋)を依頼する
価格

※ドル建て価格の商品のお支払いは、銀行レート (TTS: 107.78) 換算による円建てのご請求書にて承ります。

US $ 4,950 換算 -> ¥ 533,511 (税抜) Web Access (Regional License)
US $ 5,450 換算 -> ¥ 587,401 (税抜) Hard Copy & Web Access (Regional License)
商品コード : 22368